GlassScriptPhysician profile
Ken Samith Oerding
NPI 1306379359
$531.81
in general payments reported to CMS, 2019-2025
16 companies · $36.98 in 2025
The $36.98 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.09 · 2022: $123 · 2023: $130 · 2024: $201 · 2025: $36.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $115.05 | 2023 | |
| Lilly USA, LLC | $46.04 | 2021-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.75 | 2024 | Tradjenta, Jardiance |
| Abbvie INC. | $39.08 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $31.01 | 2023-2024 | Quviviq |
| Boston Scientific Corporation | $30.06 | 2024 | Na |
| Otsuka America Pharmaceutical, INC. | $29.14 | 2024 | Rexulti |
| Depuy Synthes Sales INC. | $27.70 | 2024 | Orthovisc |
| Bayer Healthcare Pharmaceuticals INC. | $25.94 | 2024 | |
| Glaxosmithkline, LLC. | $24.79 | 2022 | |
| Alkermes, INC. | $24.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $23.05 | 2021 | |
| Neurocrine Biosciences, INC. | $22.57 | 2022 | |
| Lundbeck LLC | $18.89 | 2025 | Rexulti |
| Scilex Pharmaceuticals INC. | $15.47 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Oerding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.